Increased Hemodialysis Sessions during Pregnancy Improve Fetal Development and Reduce Mortality: Literature Review

Renal failure is a chronic disease of complex treatment and has a great impact on people’s quality of life. Pregnancy in women on renal replacement therapy is considered high risk, requiring specific care to promote adequate treatment and improvement in maternal and fetal outcomes. This study consists in evidencing the effects of the increase of hemodialysis sessions on the health of pregnant women with Chronic Renal Insufficiency. The profile is based on women between 18 and 44 years of childbearing age. To this end, it seeks to identify the profile of women who become pregnant on dialysis treatment and outcomes. This is an integrative review, with selection of articles from the Virtual Health Library and the PUBMED from the last five years on the subject. The results show that increasing from four to six weekly hemodialysis sessions was related to decreased maternal-fetal mortality risks, and increasing gestational length from 31 to 34 weeks reduced rates of preterm births. The studies reviewed provide evidence of the benefit of increased hemodialysis sessions in dialysis pregnant women, reducing complications and improving the quality of life of the pregnant woman and the child.